US Market Report for Orthopedic Growth Factor 2017; New Report Launched

Bangalore, Karnataka -- (SBWire) -- 03/17/2017 --General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

The U.S. market reacted strongly to public opinion on the backlash of product INFUSE® for its performance. Initially approved for spinal fusion in 2001, INFUSE® was subsequently approved for tibial fractures in 2004, then for dental operations in 2007. Lawsuits have accused Medtronic of hiding side effects and promoting unapproved use. The decline seen in unit sales in 2013 can be attributed to the controversy and lawsuits surrounding the misuse of INFUSE® for unapproved indications in the spine.

Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body's ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications. Since September 1, 2015, there are two main growth factor products offered in the U.S. market: INFUSE® by Medtronic and AUGMENT® by Wright Medical. Stryker's OP-1™ which had been sold to Olympus Biotech is no longer available as Olympus Biotech ceased sales May 31, 2014. Stryker's OP-1™ is a different form of bone morphogenic proteins (BMPs) that belong to a larger family of proteins called transforming growth factors.

Spanning over 454 pages "US Market Report for Orthopedic Growth Factor 2017 - MedCore" report covers Executive Summary, U.S. Orthopedic Biomaterials Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Product Assessment, Orthopedic Growth Factor Market, Appendix. The report covered companies are - Medtronic, Genzyme, DePuy Synthes, Anika Therapeutics, Ferring Pharmaceuticals, Stryker, NuVasive, Bioventus, Zimmer Biomet, Integra LifeSciences, RTI Surgical, Fidia Pharmaceuticals, MTF, Orthofix, Arthrex, AlloSource, Aastrom, Baxter, Harvest Technologies, Wright Medical, Bacterin International, Arteriocyte, Exactech, LifeNet Health, Biocomposites, Alphatec Spine, Celling Biosciences, Globus Medical, Nuo Therapeutics, K2M

For more information Visit at: http://www.drugpipeline.net/idata-research/us-market-report-orthopedic-growth-factor-2017-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.